Cyprotex

Derisk your projects better, faster, and safer. Meet our Safety Assessment and ADME-Tox experts at the 45th Annual Meeting of the American College of Toxicology this November in Austin! Why Meet Us? - Expert Insights: Gain valuable knowledge from industry leaders. - Innovative Solutions: Discover cutting-edge strategies to derisk your projects. - Personalized Advice: Get tailored recommendations to ensure your project's success. Request a meeting with our experts today and take the first step towards safer, more efficient outcomes. Learn More & Schedule a Meeting: https://hubs.ly/Q02XtRDq0 #ACT2024 #Toxicology #SafetyAssessment #ADMETox

Did you know that cold storage units, particularly ultra-low temperature (ULT) freezers installed in our laboratories, use an incredible amount of energy? In fact, just one ULT freezer can consume as much energy as an average family home. To address this, Evotec signed up to The International Laboratory Freezer Challenge – a partnership project between My Green Lab and the International Institute for Sustainable Laboratories (I2SL). Learn about Evotec’s commitment to environmental sustainability and its role in the Freezer Challenge. Read our blog to learn more- https://hubs.ly/Q02W_VC80 #EnvironmentalSustainability #FreezerChallenge #SustainabilityGoals

Evotec SE today announced its financial results and corporate updates for the third quarter of 2024, highlighting strategic progress across key partnerships and operations. To learn more, read the full press release - https://hubs.ly/Q02X4w190

Don’t miss our upcoming webinar, Drugging the Gut Microflora to Reduce Drug Toxicity, hosted by Technology Networks, where we will explore how gut bacteria influence drug metabolism and potential toxicity. Date: 6th November 2024 Time: 4pm GMT | 5pm CET | 11am EST | 8am PST Host: Technology Networks Register Now: https://hubs.ly/Q02VHGWV0 #researchneverstops #cyprotex #webinar

Evotec SE has announced the sale of its chemical API manufacturing site, Evotec DS GmbH, located in Halle/Westphalia, to Monacum Partners GmbH - a Munich based Private Equity firm. This transaction forms part of Evotec’s “Priority Reset” initiative launched in April 2024, which aims to foster profitable growth by refining the company’s operational footprint and focusing on its primary growth sectors and core competencies. To learn more, read the full press release- https://hubs.ly/Q02WWSYX0

New blog! Discover how AI, machine learning, and in vitro assays are revolutionizing cardiotoxicity risk assessment in drug discovery. Explore our latest advancements in predicting cardiac risks, improving drug safety, and accelerating the development process. Check out the full blog here: https://hubs.ly/Q02SjSzR0 #AI #MachineLearning #DrugDiscovery #Cardiotoxicity

Join us for our upcoming webinar, Drugging the Gut Microflora to Reduce Drug Toxicity, hosted by Technology Networks, where we will explore how gut bacteria influence drug metabolism and potential toxicity. Date: 6th November 2024 Time: 4pm GMT | 5pm CET | 11am EST | 8am PST Host: Technology Networks Registration link:https://hubs.ly/Q02VHHms0 #researchneverstops #cyprotex #webinar

Evotec SE announced progress within the company’s strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline. Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology, triggering a program-based payment of US$ 50 m to Evotec. Based on potential program-based milestones, the expansion contributes to the deal value. Read the full press release to learn more- https://hubs.ly/Q02Vq--N0 #TogetherForMedicinesThatMatter #MolecularGlueDegraders #Proteomics

Meet our expert, Joanne Wilcock, from the Drug Metabolism team at Cyprotex and learn more about our services here: https://hubs.ly/Q02TNnVK0 Contact us to learn more about our ADME services at: [email protected]. #researchneverstops #cyprotex #ADME

At the upcoming SLAS Sample Management Symposium, hosted at Evotec's Campus Curie site in Toulouse, the Evotec and Cyprotex teams are presenting multiple posters which showcase our commitment to advancing sample management through innovative technologies and optimized processes. Our poster titles and authors include: 16 October session: • Isabelle Bergere: BraMosA: Our New Smartcel-2 boosting Serial Dilution Preparation • Kevin Joseph Cross: Cyprotex Sample Management – Supporting Our Future • Suzana Khoder: Transferring Evotec’s Screening Library to AcoustiX Tubes: State-of-the-Art Technology at the Service of Increased Efficiency and Reduced Compound Consumption • Delphine Merat: Up-to-date technology and optimized organization for Sample Management 17 October poster session: • Isabelle Bergere: Leveraging Sample Management Strengths to Support Biologics Research • Isabelle Bergere: No compromise! Combining Quality, Flexibility and Reliability with the new JFM integration for the CyBio well Vario • Emiliano Cuadrado Rodriguez: Evotec’s Basic Performance Verification processes for DMSO based liquid handlers • Fabrice Turlais: Setting up biological storage capabilities in Sample Management, Evotec Toulouse For more info, and to schedule a meeting with us, visit here: https://hubs.ly/Q02T6Lpf0 We look forward to seeing you in Toulouse and to discussing our science with you. #SLAS2024 #SampleManagement #DrugDiscovery